The early study revealed that CCL2-null 4T1 cells elicited enhanced cytotoxic T cell recruitment and IFN-γ secretion in vivo and in vitro, while CCL2-deletion did not show enhanced immunogenicity of the total tumor (127). The gene discussed is IFNG; the disease is neoplasm.